Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 19/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.50 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164698 | 0.85 | NAMPT (1.00) | NAMPTCYP2C9 | |
| SCHEMBL22069595 | 0.73 | RECQL (0.77) | NAMPT | |
| SCHEMBL21324718 | 0.71 | NAMPT (0.74) | NAMPTCYP2C9 | |
| SCHEMBL19860110 | 0.71 | IMPDH2 (0.59) | — | |
| SCHEMBL165318 | 0.71 | NAMPT (0.98) | NAMPT | |
| SCHEMBL20379446 | 0.70 | NAMPT (1.00) | NAMPT | |
| SCHEMBL165190 | 0.70 | NAMPT (0.82) | NAMPTCYP2C9 | |
| SCHEMBL163603 | 0.70 | NAMPT (1.00) | NAMPT | |
| SCHEMBL160345 | 0.70 | NAMPT (1.00) | NAMPT | |
| SCHEMBL29635819 | 0.69 | NAMPT (1.00) | NAMPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10329275-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2019-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329275-B2 | Compounds and compositions for the inhibition of NAMPT | NAMPT, NNT, NQO1 | NAMPT 1/4885CYP2C9 446/4885NCOA1 1304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.